• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Diseases & Conditions
  • All Diseases and Conditions
  • Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis (STRATUS)

Disease
bronchiectasis
Drug Name
AZD5069
Generic Name
AZD5069
Sponsor
AstraZeneca
Drug Status
In Development
Phase
II
Start Date
Feb 8, 2011
Study Name
D3550C00014
Study Id
D3550C00014
ClinicalTrials.gov ID
NCT01255592
Recruiting Status
Closed
Protocol Status
Not Available
Report Status
Not Available

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013